Citation: | CHEN Siyu, BAI Lan, ZHOU Yu. The expression of irregular fractalkine in patients with preeclampsia and its relationships with inflammatory factors and pregnancy outcomes[J]. Journal of Clinical Medicine in Practice, 2023, 27(16): 84-88. DOI: 10.7619/jcmp.20230192 |
To investigate the relationship between the expression of irregular fractalkine (FKN) and serum inflammatory factors as well as pregnancy outcomes in patients with preeclampsia (PE).
A total of 152 patients with PE were selected as study objects. According to the pregnancy outcomes of all PE patients, they were divided into normal pregnancy outcome group and adverse pregnancy outcome group. The general data of patients were collected, and serum levels of FKN, tumor necrosis factor-α(TNF-α) were detected by enzyme-linked immunosorbent assay, the level of high-sensitivity C-reactive protein (hs-CRP) was detected by immunoturbidimetry, and the expression of FKN in placental tissue was detected by immunohistochemistry.
The diastolic blood pressure, systolic blood pressure, levels of serum TNF-α, serum hs-CRP, serum FKN and the positive rate of tissue FKN in the adverse pregnancy outcome group were significantly higher than those in the normal pregnancy outcome group (P < 0.05). There were positively correlations of the expression of serum FKN in PE patients with diastolic blood pressure, systolic blood pressure, serum TNF-α and hs-CRP (P < 0.05). The high expression of serum TNF-α, high expression of serum hs-CRP, high expression of serum FKN and positive FKN in placenta tissue were independent risk factors for adverse pregnancy outcomes in patients with PE (P < 0.05); excessive gestational weeks were a protective factor for adverse pregnancy outcomes in PE patients (P < 0.05). The areas under the curve of serum TNF-α, hs-CRP, FKN and FKN level in placenta tissue in predicting adverse pregnancy outcomes in PE patients were 0.615 (95%CI, 0.522 to 0.708), 0.681 (95%CI, 0.595 to 0.767), 0.766 (95%CI, 0.690 to 0.842) and 0.702 (95%CI, 0.619 to 0.785), respectively.
FKN is highly expressed in serum and placental tissue of patients with PE, and their expression levels are related to serum inflammatory factors and adverse pregnancy. Both of them have high predictive value for adverse pregnancy outcomes in patients with PE.
[1] |
TURBEVILLE H R, SASSER J M. Preeclampsia beyond pregnancy: long-term consequences for mother and child[J]. Am J Physiol Renal Physiol, 2020, 318(6): F1315-F1326. doi: 10.1152/ajprenal.00071.2020
|
[2] |
IVES C W, SINKEY R, RAJAPREYAR I, et al. Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2020, 76(14): 1690-1702. doi: 10.1016/j.jacc.2020.08.014
|
[3] |
KORBECKI J, SIMINSKA D, KOJDER K, et al. Fractalkine/CX3CL1 in neoplastic processes[J]. Int J Mol Sci, 2020, 21(10): 3723. doi: 10.3390/ijms21103723
|
[4] |
吴淼, 钟江华, 彭振宇, 等. 原发性高血压患者血清Fractalkine水平与血管内皮功能损伤的相关性研究[J]. 中国现代医学杂志, 2018, 28(1): 103-107. doi: 10.3969/j.issn.1005-8982.2018.01.020
|
[5] |
朱秀, 易敏, 张利容. 血清Fractalkine、Vaspin水平与重度子痫前期患者心功能关系[J]. 中国计划生育学杂志, 2020, 28(11): 1880-1883. https://www.cnki.com.cn/Article/CJFDTOTAL-JHSY202011041.htm
|
[6] |
马国珺, 庄旭, 吕鑫, 等. 子痫前期患者妊娠晚期24 h动态血压数据与不良妊娠结局的相关性分析[J]. 现代妇产科进展, 2021, 30(6): 420-425. https://www.cnki.com.cn/Article/CJFDTOTAL-XDFC202106006.htm
|
[7] |
HAUSPURG A, JEYABALAN A. Postpartum preeclampsia or eclampsia: defining its place and management among thehypertensive disorders of pregnancy[J]. Am J Obstet Gynecol, 2022, 226(2S): S1211-S1221.
|
[8] |
STAFF A C, FJELDSTAD H E, FOSHEIM I K, et al. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia[J]. Am J Obstet Gynecol, 2022, 226(2S): S895-S906.
|
[9] |
ADU-GYAMFI E A, FONDJO L A, OWIREDU W K B A, et al. The role of adiponectin in placentation and preeclampsia[J]. Cell Biochem Funct, 2020, 38(1): 106-117. doi: 10.1002/cbf.3458
|
[10] |
PEREIRA M M, TORRADO J, SOSA C, et al. Shedding light on the pathophysiology of preeclampsia-syndrome in the era of cardio-obstetrics: role of inflammation and endothelial dysfunction[J]. Curr Hypertens Rev, 2022, 18(1): 17-33. doi: 10.2174/1573402117666210218105951
|
[11] |
ROZAS-VILLANUEVA M F, CASANELLO P, RETAMAL M A. Role of ROS/RNS in preeclampsia: are connexins the missing piece?[J]. Int J Mol Sci, 2020, 21(13): 4698. doi: 10.3390/ijms21134698
|
[12] |
XIE Y, LI X X, LV D, et al. TREM-1 amplifies trophoblastic inflammation via activating NF-κB pathway during preeclampsia[J]. Placenta, 2021, 115: 97-105. doi: 10.1016/j.placenta.2021.09.016
|
[13] |
吕冬梅, 尚敏捷, 田晓颖, 等. 子痫前期患者血清miR-155表达及其与炎症因子和妊娠结局的关系[J]. 国际检验医学杂志, 2021, 42(5): 585-589. doi: 10.3969/j.issn.1673-4130.2021.05.016
|
[14] |
LEE S, DENEEN B, RAO G. CX3CR1 and malignant progression of glioma[J]. Aging, 2021, 13(17): 20856-20857. doi: 10.18632/aging.203536
|
[15] |
SZEWCZYK G, PYZLAK M, PANKIEWICZ K, et al. The potential association between a new angiogenic marker fractalkine and a placental vascularization in preeclampsia[J]. Arch Gynecol Obstet, 2021, 304(2): 365-376. doi: 10.1007/s00404-021-05966-3
|
[16] |
HUANG S J, CHEN C P, BUCHWALDER L, et al. Regulation of CX3CL1 expression in human first-trimester decidual cells: implications for preeclampsia[J]. Reprod Sci, 2019, 26(9): 1256-1265. doi: 10.1177/1933719118815592
|
[17] |
LI H, ZHANG H M, FAN L J, et al. STAT3/miR-15a-5p/CX3CL1 loop regulates proliferation and migration of vascular endothelial cells in atherosclerosis[J]. Int J Med Sci, 2021, 18(4): 964-974. doi: 10.7150/ijms.49460
|
[18] |
NEMSKA S, GASSMANN M, BANG M L, et al. Antagonizing the CX3CR1 receptor markedly reduces development of cardiac hypertrophy after transverse aortic constriction in mice[J]. J Cardiovasc Pharmacol, 2021, 78(6): 792-801. doi: 10.1097/FJC.0000000000001130
|
[19] |
NONN O, GVTTLER J, FORSTNER D, et al. Placental CX3CL1 is deregulated by angiotensin Ⅱ and contributes to a pro-inflammatory trophoblast-monocyte interaction[J]. Int J Mol Sci, 2019, 20(3): 641. doi: 10.3390/ijms20030641
|
[20] |
陈其敬, 罗江宾, 张云波, 等. 原发性高血压患者血清FKN水平与血管内皮功能的关系[J]. 中国医药导报, 2018, 15(23): 45-48. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201823012.htm
|